Novartis AG ADR sell The Goldman Sachs Group, Inc.
Start price
12.09.25
/
50%
€106.50
Target price
12.09.26
€100.61
Performance (%)
11.27%
Price
30.12.25
€118.50
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 11.27%. This prediction currently runs until 12.09.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novartis AG ADR | 0.000% | 0.000% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis (NYSE:NVS) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $118.00 price target on the stock, down previously from $119.00.
Ratings data for NVS provided by MarketBeat